UPMC Hillman Cancer Center Passavant (OHA) — Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center Passavant (OHA) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15237.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center Passavant (OHA) has participated in 2 clinical trials.

Therapeutic areas: Primary Invasive Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Myriad Genetic Laboratories, Inc., Ronald Buckanovich.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center Passavant (OHA)?

UPMC Hillman Cancer Center Passavant (OHA) has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center Passavant (OHA) conducted?

UPMC Hillman Cancer Center Passavant (OHA) has 2 clinical trials on record. Their work covers Primary Invasive Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer.

Is UPMC Hillman Cancer Center Passavant (OHA) accredited by Crixeo Health?

UPMC Hillman Cancer Center Passavant (OHA) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center Passavant (OHA)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.